catechin has been researched along with Hepatitis B in 19 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 16 (84.21) | 18.7374 |
1990's | 1 (5.26) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (5.26) | 24.3611 |
2020's | 1 (5.26) | 2.80 |
Authors | Studies |
---|---|
Gao, B; Guo, ZW; Li, YQ; Lu, MD; Wang, ZY; Xue, TC; Zhou, XH | 1 |
Chen, JC; Huang, C; Huang, HC; Hung, TM; Lin, ZJ; Tao, MH | 1 |
Yamamoto, S | 1 |
Jávor, T; Kádas, I; Kerekes, E; Nagy, I; Paál, M; Pár, A | 1 |
Jávor, T; Kádas, I; Kerekes, E; Paál, M; Pár, A | 1 |
Babiuch, L; Poznańska, H; Rychalska, B | 1 |
Mierzejewska, I; Patorska-Mach, E; Rzeszowska, G | 1 |
Angela, GC; Bendiscioli, L; Bramato, C; Di Nola, F; Fiorio, C; Marino, M; Salassa, B; Soranzo, ML | 1 |
Modrzewska, R; Radomińska, I; Rzeszowska, G | 1 |
Berthet, P; Blum, AL; Doelle, W; Goebell, H; Kortüm, K; Pelloni, S; Peter, P; Poulsen, H; Strohmeyer, G; Tygstrup, N | 1 |
Boroń, P; Boroń-Kaczmarska, A; Nadowska, K; Sokolewicz-Bobrowska, E; Szpakowicz, T | 1 |
Suzuki, H | 1 |
Judmaier, G | 1 |
Ishii, H; Kanai, K; Matsuda, H; Matsumoto, M; Mizushima, N; Morioka, S; Nakajima, T; Takehira, Y; Tamakoshi, K | 1 |
Rauch, G | 1 |
Fujisawa, K; Hirayama, C; Oda, T; Suzuki, H; Takino, T; Yamamoto, S | 1 |
Anderson, MG; Keeling, PW; Macartney, JC; Marigold, JH; Murray-Lyon, IM; Paradinas, FJ; Thompson, RP; Viola, L | 1 |
Jávor, T; Pácsa, S; Pár, A; Szekeres-Bartho, J | 1 |
1 review(s) available for catechin and Hepatitis B
Article | Year |
---|---|
[Epidemiology, clinical aspects and prognosis of viral hepatitis A, B and non-A, non-B].
Topics: Catechin; Cross-Sectional Studies; Hepatitis A; Hepatitis Antibodies; Hepatitis B; Hepatitis C; Hepatitis Viruses; Hepatitis, Viral, Human; Humans; Prognosis; Risk Factors | 1988 |
8 trial(s) available for catechin and Hepatitis B
Article | Year |
---|---|
(+)-cyanidanol-3.
Topics: Acute Disease; Benzopyrans; Catechin; Clinical Trials as Topic; Flavonoids; Hepatitis B; Humans; Liver Diseases | 1982 |
Experiences with Catergen treatment in chronic active hepatitis.
Topics: Adult; Aged; Aminoimidazole Carboxamide; Catechin; Clinical Trials as Topic; Female; Hepatitis B; Hepatitis, Chronic; Humans; Male; Middle Aged | 1983 |
Effect of (+)-cyanidanol-3 (Catergen) in chronic active hepatitis. (Catergen plus prednisolone versus prednisolone in a controlled study).
Topics: Benzopyrans; Catechin; Drug Therapy, Combination; Hepatitis B; Hepatitis, Chronic; Humans; Liver Function Tests; Prednisolone | 1983 |
[Effect of catergen on the course of acute viral hepatitis].
Topics: Acute Disease; Antiviral Agents; Benzopyrans; Catechin; Clinical Trials as Topic; Hepatitis B; Hepatitis C; Hepatitis, Viral, Human; Humans; Random Allocation | 1981 |
Treatment of acute viral hepatitis with (+)-cyanidanol-3.
Topics: Adult; Alkaline Phosphatase; Aspartate Aminotransferases; Benzopyrans; Bilirubin; Catechin; Clinical Trials as Topic; Double-Blind Method; Female; Follow-Up Studies; Hepatitis B; Hepatitis B Antigens; Hepatitis, Viral, Human; Humans; Liver Function Tests; Male; Middle Aged; Placebos; Prospective Studies | 1977 |
[Evaluation of therapeutic effect of catergen in viral hepatitis].
Topics: Adolescent; Adult; Aged; Antiviral Agents; Benzopyrans; Catechin; Clinical Trials as Topic; Female; Hepatitis B; Hepatitis C; Hepatitis, Viral, Human; Humans; Male; Middle Aged | 1979 |
Cianidanol therapy for HBe-antigen-positive chronic hepatitis: a multicentre, double-blind study.
Topics: Adolescent; Adult; Aged; Benzopyrans; Catechin; Clinical Trials as Topic; Double-Blind Method; Female; Hepatitis B; Hepatitis B Antibodies; Hepatitis B e Antigens; Hepatitis, Chronic; Humans; Liver Function Tests; Male; Middle Aged; Random Allocation | 1986 |
Trial of (+)-cyanidanol-3 in patients with hepatitis B chronic liver disease.
Topics: Catechin; Chronic Disease; Clinical Trials as Topic; Double-Blind Method; Female; Hepatitis B; Hepatitis B Surface Antigens; Humans; Liver; Male | 1986 |
10 other study(ies) available for catechin and Hepatitis B
Article | Year |
---|---|
ERK1/2-HNF4α axis is involved in epigallocatechin-3-gallate inhibition of HBV replication.
Topics: Animals; Antiviral Agents; Catechin; Disease Models, Animal; Dose-Response Relationship, Drug; Gene Expression Regulation, Viral; Hep G2 Cells; Hepatitis B; Hepatitis B virus; Hepatocyte Nuclear Factor 4; Humans; Mice; Mice, Inbred C57BL; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Virus Replication | 2020 |
(-)-Epigallocatechin-3-gallate inhibits entry of hepatitis B virus into hepatocytes.
Topics: Antiviral Agents; Catechin; Cell Line; Hepatitis B; Hepatitis B virus; Hepatocytes; Humans; Plant Extracts; Virus Internalization; Virus Replication | 2014 |
[Immune stimulator therapy].
Topics: Adjuvants, Immunologic; Catechin; Chronic Disease; Hepatitis B; Humans; Interleukin-1; Picibanil; T-Lymphocytes | 1984 |
[Observations on the use of catergen (Zyma) in the treatment of hepatic coma].
Topics: Acute Disease; Adult; Antiviral Agents; Benzopyrans; Catechin; Female; Hepatic Encephalopathy; Hepatitis B; Humans | 1980 |
[Chronic hepatitis caused by B virus (HBV)].
Topics: Adrenal Cortex Hormones; Antibodies, Viral; Azathioprine; Catechin; Chronic Disease; Hepatitis B; Hepatitis B Surface Antigens; Hepatitis B virus; Humans; Immunoglobulins; Immunosuppressive Agents; Liver; Penicillamine; Transaminases | 1980 |
[Clinical analysis of 4 cases of severe viral hepatitis treated with catergen].
Topics: Adult; Aged; Antiviral Agents; Benzopyrans; Catechin; Female; Hepatitis B; Humans; Male; Middle Aged | 1980 |
[Treatment of hepatitis B].
Topics: Catechin; Chronic Disease; Hepatitis B; Humans; Interferon Type I; Liver Function Tests; Prednisolone; Vidarabine | 1990 |
Treatment of chronic hepatitis B with recombinant leukocyte interferon and cyanidanol.
Topics: Adult; Catechin; Hepatitis B; Hepatitis B e Antigens; Hepatitis, Chronic; Humans; Interferon Type I; Liver Function Tests; Male; Recombinant Proteins | 1988 |
The immunoenhancing effect of cianidanol (C) on macrophages and on the T-cell system.
Topics: Adjuvants, Immunologic; Benzopyrans; Catechin; Hepatitis B; Hepatitis, Chronic; Humans; Immunoglobulins; In Vitro Techniques; Lymphocyte Activation; Macrophages; Rosette Formation; T-Lymphocytes | 1986 |
Effect of cianidanol on natural killer cell activity in patients with chronic B virus hepatitis.
Topics: Adult; Aged; Aged, 80 and over; Catechin; Chronic Disease; Female; Hepatitis B; Humans; In Vitro Techniques; Killer Cells, Natural; Male; Middle Aged | 1987 |